Related Experiment Video
Updated: Apr 28, 2026

A Novel Feeder-free System for Mass Production of Murine Natural Killer Cells In Vitro
Published on: January 9, 2018
Positive and negative regulation by NK cells in cancer
Can M Sungur1, William J Murphy2
1Department of Dermatology, University of California, Davis, Sacramento, CA 95817.
Abstract:
Our understanding of NK biology has expanded immensely since the initial discovery of natural killer cells in 1975. New studies have uncovered various levels of immune regulation both on and by unique subsets of NK cells, which go well beyond simple receptor-ligand interactions between NK cells and target cancer cells. Distinct suppressor and effector populations of NK cells have been delineated in both viral and tumor models. Interactions between NK cells and dendritic cells, T cells, and B cells also dramatically alter the overall immune response to cancer. To exploit the diverse functional abilities of NK cell subsets for cancer immunotherapies, it is important to understand NK cell biology and NK regulator mechanisms.
Insights
Natural killer (NK) cell research has revealed complex immune regulation beyond basic interactions. Understanding these diverse NK cell subsets and their regulatory mechanisms is crucial for developing effective cancer immunotherapies.
Area of Science:
- Immunology
- Cancer Biology
- Cellular Immunology
Background:
- Natural killer (NK) cells were discovered in 1975.
- Recent research shows intricate immune regulation involving NK cell subsets.
- NK cell functions extend beyond simple receptor-ligand interactions with cancer cells.
Purpose of the Study:
- To review the expanding understanding of NK cell biology.
- To highlight the complex regulatory mechanisms governing NK cells.
- To emphasize the importance of this knowledge for cancer immunotherapy development.
Main Methods:
- Review of recent scientific literature on NK cell biology and regulation.
- Analysis of studies identifying distinct NK cell subsets (suppressor and effector).
- Examination of NK cell interactions with other immune cells (dendritic cells, T cells, B cells).
Main Results:
- NK cell regulation involves multiple levels, not just receptor-ligand interactions.
- Distinct suppressor and effector NK cell populations have been identified in viral and tumor models.
- Interactions between NK cells and other immune cells significantly influence anti-cancer immune responses.
Conclusions:
- NK cell biology is more complex than previously understood, involving diverse subsets and regulatory networks.
- Understanding these complex mechanisms is essential for harnessing NK cell potential in cancer immunotherapy.
- Further research into NK cell subsets and regulators will drive advancements in cancer treatment.
More Related Videos
06:55Measurement of Natural Killer Cell-Mediated Cytotoxicity and Migration in the Context of Hepatic Tumor Cells
Published on: February 22, 2020
09:54Assessment of Human Natural Killer Cell Events Driven by FcγRIIIa Engagement in the Presence of Therapeutic Antibodies
Published on: May 22, 2020
Related Concept Videos
Immune Surveillance by NK Cells and Phagocytes
Natural Killer Cells: The Fast Responders
NK cells are large granular lymphocytes found in the blood and lymphatic system. These...
Cells of the Innate Immune Response
Phagocytes
Phagocytes police the peripheral tissues by removing cellular debris and responding to the invasion of foreign substances or pathogens. Many phagocytes attack and remove microorganisms even before lymphocytes detect them. The human body has two general...
Cytotoxic T Cells-mediated Immune Response
Immunological surveillance is the ability of immune cells to monitor and eliminate infected cells with intracellular pathogens, neoplastically transformed cells, and cells with non-self antigens. Cytotoxic T cells and NK...
Receptor Downregulation in MVBs
The EGFR can initiate signaling pathways that lead to cell proliferation, migration, and differentiation. Overexpression of EGFR stimulates cells to proliferate. Excessive EGFR...
Negative Regulator Molecules
Cancer